Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population
{{output}}
Background: Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies have emerged as promising therapeutic options for the treatment of chronic migraine. However, treatment response varies considerably among individuals,... ...
